COAGULATION FACTOR XIII - ANVISA Registration 80102510713

Access comprehensive regulatory information for COAGULATION FACTOR XIII in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102510713 and manufactured by DIAGNOSTICA STAGO S.A.S.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80102510713
Registration Details
ANVISA Registration Number: 80102510713
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

FACTEUR XIII REACTIFS
Risk Class II

Registration Details

80102510713

25351288783200918

04718143000194

Company Information

France
PT: FRANÇA

Dates and Status

Oct 05, 2009

VIGENTE

09/18/2025 19:00:01